Body fatness is now a well-established risk factor for colon cancer; however the potential 84 mechanisms behind this relation are largely unknown. In a nested case-control study among 
Adiposity, Mediating Biomarkers and Risk of Colon Cancer in the European
. Thus, recent EPIC findings suggested an 158 important role of soluble leptin receptor (sOB-R) 12 and non-high-molecular-weight (HMW) 159 adiponectin in colon cancer risk 13 . However, it remains to be answered to what extent these 160 metabolic biomarkers may explain the association of adiposity with colon cancer. It is also 161 unclear to what extent the role of these potential mediating biomarkers differs between men 162 and women given the known differences in body shape and fat accumulation between sexes. Incident cancer cases were identified through record linkage with regional cancer 180 registries or using a combination of methods, including health insurance records, cancer and 181 pathology registries, and active follow-up through study subjects and their next-of-kin.
182
Closure dates for the present study were defined as the latest date of complete follow-up for 
197
Premenopausal women were matched on phase of the menstrual cycle at blood collection, and 198 postmenopausal women were matched on current use of hormone replacement therapy.
199

Exclusion criteria and management of missing data
200
Excluded from the analysis were the subjects from Norway and the Malmö center in
201
Sweden which did not provide blood samples for the current study, as well as subjects with 16 . All variables in the regression model were included in the procedure. were stored in the vapour phase of liquid nitrogen (-150 °C) or in -80°C freezers, respectively.
219
The blood collection and processing protocols are described in detail elsewhere , and sOB-R 12 has been described elsewhere.
224
Statistical methods
225
Spearman partial correlation coefficients, adjusted for age at study recruitment and case- 
247
The corresponding 95% confidence intervals (CI) were calculated based on Fieller's theorem . Finally, to test the significance of mediation effect, we applied the Sobel's test 25, 26 . In 249 sensitivity analyses, we repeated the main multivariable adjusted analysis after excluding 250 cases diagnosed in the first 2 years of follow up (n=173); we also repeated the analysis for 251 markers that may be influenced by fasting status, such as C-peptide, after excluding non-252 fasting participants (n = 642). 
Results
257
The baseline characteristics of incident colon cancer cases and their corresponding controls in 258 men and women are presented in Table 1 . Overall, cases of colon cancer had higher 259 concentrations of C-peptide, CRP-hs and ROM, and lower concentrations of non-HMW 260 adiponectin and sOB-R compared to controls. WC and BMI were highly correlated with each 261 other in both men (r = 0.84) and women (r = 0.83).
262
All biomarkers were correlated with both WC and BMI with the exception of IGF-1
263
( Table 2 ). The associations among the different biomarkers were in the expected direction and 264 ranged from weak to moderate strength (Table 3) . Of note, since IGF-1 was not correlated to 265 obesity measures, it did not fulfill the requirements of being a potential mediating variable; 266 therefore we did not include it in subsequent mediation analyses.
267
In multivariable adjusted logistic regression, WC was associated with risk of colon 268 cancer in both men and women (top vs bottom tertile, RR 1.68, 95% CI 1.06 -2.65, ; P trend = 269 0.02 in men; RR 1.67, 95% CI 1.09 -2.56, P trend = 0.03 in women; Table 4 ). In subsequent 270 analyses, we assessed the association of colon cancer with WC continuously per 10 cm 271 increase and estimated the percent change in regression coefficients after adjustment for each 272 biomarker (Table 5) . sOB-R, non-HMW-adiponectin and HDL-C were the three biomarkers 273 that explained to the greatest extent the association individually and in combination explained 274 46% (95% CI 37 to 57%) of the association in men and 50% (95% CI 40 to 65%) of the 275 association in women ( Table 5 ). Factors that differentially explained the association by sex 276 were ROM, which accounted for 21% (95% CI 16 to 26%) of the association in men and 8%
277
(95% CI 9 to 12%) of the association in women; as well as C-peptide, accounting for 30% 278 (95% CI 22 to 40%) of the association in women and -9% (95% CI -14 to -4%) of the 279 association in men. When we included ROM (as a biomarker more strongly explaining the 280 association in men compared to women) in combination with the three most important 281 biomarkers (sOB-R, non-HMW adiponectin and HDL-C), the percent change in risk was 71%
282
(95% CI 58 to 86%) in men and 58% (95% CI 47 to 75%) in women; when instead we 283 included C-peptide (as a biomarker more strongly explaining the association in women 284 compared to men) in the same model, the respective values were 33% (95% CI 24 to 44%) in 285 men and 53% (95% CI 40 to 68%) in women (Table 5 ). The results from the Sobel's test 286 further confirmed that the association between WC and colon cancer was statistically significantly mediated by sOB-R, non-HMW adiponectin and HDL-C (Supplementary Table   288 2). Table 3 ).
295
No substantial differences in risk estimates were observed after excluding people diagnosed 296 with cancer during the first two years of follow-up, or non-fasting participants (for C-peptide)
297
(data not shown).
298
Discussion
299
In this nested case-control study, the three biomarkers that explained the largest 300 proportion of the association of adiposity with colon cancer risk were HDL-C, non-HMW 301 adiponectin and sOB-R. Factors that differentially explained the association in men and 302 women were ROM and C-peptide. These findings support the hypothesis that pathways 303 reflected by these biomarkers maybe responsible for mediating the effects of adiposity on 304 colon cancer risk.
305
As shown previously in EPIC 3 , in our analysis, WC was associated with colon cancer 306 risk in men and in women; whereas BMI showed an association only among men. Since WC 307 is more strongly related to abdominal fat accumulation than BMI, these findings suggest that 308 it is particularly visceral fat that may increase colon cancer risk. Thus, more precise 309 characterization of the risk-defining obesity phenotype may be achieved in a simple way by 310 measuring WC in addition to BMI, but also by using metabolic biomarkers.
311
In our data, non-HMW adiponectin and sOB-R, accounted for the largest proportion of 312 the adiposity-colon cancer association. Adiponectin, the most abundant protein secreted by adipose tissue, exerts insulin-sensitizing, anti-inflammatory, anti-atherogenic, pro-apoptotic, 314 and anti-proliferative properties 27 . In contrast to other adipokines, adiponectin is inversely . In our data we 401 have conducted the analysis for C-peptide after excluding non-fasting participants and results
402
were not considerably changed. Further, some biomarkers that were studied in the analysis as 
408
In summary, these data suggest HDL-C, non-HMW adiponectin and sOB-R to be the Adjusted for sex and age at study recruitment. b P values in parentheses. HbA 1c; = glycated hemoglobin; HDL-cholesterol =high-density-lipoprotein cholesterol; CRP-hs = high-sensitivity C-reactive protein; ROM = reactive oxygen metabolites; HMWadiponectin = high-molecular-weight adiponectin; sOB-R = soluble leptin receptor. Multivariable model was based on the crude model with additional adjustment for smoking status (never, past, current, or unknown), education (no school degree or primary school, technical or professional school, secondary school, university degree, or unknown), alcohol intake (continuous), and physical activity (inactive, moderately inactive, moderately active, active, or missing). WC = waist circumference; HbA 1c; = glycated hemoglobin; HDL-cholesterol =high-density-lipoprotein cholesterol; CRP-hs = high-sensitivity C-reactive protein; ROM = reactive oxygen metabolites; HMW-adiponectin = high-molecular-weight adiponectin; sOB-R = soluble leptin receptor; T = tertile; P trend =P for trend across tertiles; All P values are twosided. 
